India-EU FTA Goes Live: 6 Stocks Set to Gain From Zero-Duty Access to a $370 Billion Market

Union Minister JP Nadda confirmed this week that the India-EU Free Trade Agreement is opening new doors for Indian pharmaceuticals and medical devices. Combined with the textile provisions concluded in January 2026, this FTA represents the biggest trade shift for Indian exporters in a decade. EU tariffs on Indian textiles and apparel — previously 8% to 12% — are moving to effectively zero, putting India on par with Bangladesh, Vietnam, and Turkey for the first time.

We searched corporate filings to find which companies are already positioning for this opportunity — and which ones have hard numbers to back up the thesis.

The Scale of the Opportunity

The EU textile and apparel import market exceeds $250 billion annually, per RSWM Limited's Q3 FY26 earnings call. Filatex India's management put the broader number even higher in their Q4 FY26 earnings call: "The EU represents a large and attractive market worth $370 billion, offering substantial headroom for Indian exporters." Until now, Indian companies faced an 8-12% tariff disadvantage versus duty-free competitors like Bangladesh. That disadvantage is gone.

In medical devices, the stakes are equally large. Per Poly Medicure's Q3 FY26 investor presentation, the agreement "opens access to the EU's ~$572 billion pharma and medical devices market."

Who Benefits Most: 6 Companies With Filing-Backed Evidence

1. Gokaldas Exports (GOKEX) — Already Pivoting to Europe

Gokaldas is India's largest listed apparel exporter, and they are not waiting around. Per their Q1 FY26 earnings transcript, European business share increased to over 13% of revenue from a 9% average in FY25 — a 44% jump in mix share in just one quarter. CEO S. Ganapathi stated in the Q3 FY26 transcript that "many European retailers are actively present in India trying to onboard suppliers," even before tariff benefits kick in. Management noted that India margins exceeded 13% after adjusting for one-offs, and once zero-duty access begins, "that's when the real transaction will happen." They are also expanding via Africa operations (10% US tariff on Kenya/Ethiopia) to hedge US exposure.

2. RSWM Limited (RSWM) — Man-Made Fibres Play

RSWM's management laid out the FTA case most clearly in their Q3 FY26 earnings call: "This agreement will give us a level playing field with tariff coming from 8% to 12% to almost zero, thereby enhancing our competitiveness in the global market, particularly Europe." They highlighted the man-made fibre segment specifically, "where India has historically been under-represented," as the biggest beneficiary. Their Q1 FY26 investor presentation also noted that the India-EU FTA could "enhance exports of sustainable products such as organic cotton, handloom textiles, and recycled fibers, aligning with Europe's ESG-driven procurement."

3. Welspun Living (WELSPUNLIV) — Home Textiles Leader With 20% EU Exposure

Welspun already derives ~20% of revenues from the EU and UK, per their November 2025 investor presentation. They are the #1 exporter of towels to the UK from India, with strategic partnerships with IKEA across both UK and EU markets. The company's presentation explicitly targets "multi-fold growth with upcoming India-UK and India-EU FTAs." Their licensed brands — including Disney Home (Europe) — posted 38% growth per their FY25 annual report. The medium-term aspiration is revenue of ~Rs 15,000 crores with EBITDA margins of 15-16%.

4. Filatex India (FILATEX) — Upstream Polyester Yarn

Filatex is upstream — they make the polyester yarn that becomes fabric and apparel. Their Q4 FY26 earnings transcript offered the most detailed competitive analysis: "India will effectively move to zero custom duty from 10% to 12% presently on most textile and apparel exports." They also noted a critical timing advantage: "The EU is moving towards a structure where India and Vietnam are at zero duty while Bangladesh faces a possible step-up in tariffs after 2029." This means Indian yarn makers like Filatex could see rising downstream demand as apparel makers expand EU-facing capacity.

5. Poly Medicure (POLYMED) — Medical Devices Dark Horse

The India-EU FTA is not just about textiles. Poly Medicure — India's largest exporter of consumable medical devices — dedicated an entire slide in their Q3 FY26 investor presentation to the "India EU Trade Deal Impact on Medtech Sector." They cited supply-chain integration, regulatory alignment, and access to EU's $572 billion market. Europe revenue grew approximately 30% in nine months per their FY25 investor presentation. With R&D teams already operating in Italy and Netherlands, and EBITDA margins at 25.8%, Polymed is better positioned than most to convert regulatory access into revenue.

6. S.P. Apparels (SPAL) — Europe-Facing Garment Maker

S.P. Apparels is expanding trading activities with new customers in the UK, Ireland, and other European countries, per their FY25 investor presentation. They already cater to well-known European brands like Joules and Dunnes Stores. Their presentation highlighted that the India-EU FTA and the RoSCTL export scheme "provide opportunities for exporting to newer geographies" and will "enhance the demand and profitability of SPAL." The industry body CII estimates FTAs could generate 7.5-10 million new jobs in the textile sector.

What Retail Investors Should Do

This is a structural shift, not a one-quarter trade. The FTA moves India from a tariff-disadvantaged supplier to a level-playing-field competitor in the world's second-largest consumer market. But not every textile stock wins equally — look for companies that (a) already have European customer relationships, (b) operate in value-added segments rather than commodity products, and (c) have the capacity to scale. Gokaldas and Welspun check all three boxes. RSWM and Filatex are upstream plays that benefit from rising demand across the sector. Poly Medicure is the non-obvious pick — a medical devices company that most textile-focused investors will overlook. Monitor quarterly filings for European revenue mix as the key leading indicator over the next two to three quarters.

Data sourced from company filings on NSE via Xaro.